Article: Screening battery validated for HIV-related neurocognitive impairment.

2004 NOV 16 - (NewsRx.com & NewsRx.net) -- A screening battery has been validated for persons with HIV-related neurocognitive impairment.

According to researchers in the United States, "This study sought to develop and validate a screening battery for detecting HIV-related neuropsychological (NP) impairment."

"Six NP measures representing the ability areas most likely affected by HIV infection were paired in 14 combinations and their diagnostic accuracy rates compared. The measures were selected from a larger NP battery administered to 190 HIV-seropositive (HIV+) participants.

"Screening battery performance was classified as NP impaired if ...

Related newspaper, magazine, and journal articles:

 
 
Newsweek Harper's Magazine The Washington Post Chicago Tribune Crain's Chicago Business PRNewswire Pediatric News The Nation Advertising Age The Economist (US) A FREE trial gives you access to over 80 million articles! Access over 6,500 publications with a FREE trial!